These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8109847)

  • 21. Prolongation of hamster to rat xenograft survival by rapamycin.
    Chen H; Xu D; Wu J; Daloze P
    Transplant Proc; 1992 Apr; 24(2):715-6. PubMed ID: 1566496
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of rapamycin in experimental organ allografting.
    Ochiai T; Gunji Y; Nagata M; Komori A; Asano T; Isono K
    Transplantation; 1993 Jul; 56(1):15-9. PubMed ID: 8333037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection.
    Stepkowski SM; Tian L; Napoli KL; Ghobrial R; Wang ME; Chou TC; Kahan BD
    Clin Exp Immunol; 1997 Apr; 108(1):63-8. PubMed ID: 9097913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapamycin reverses acute heart, kidney, and pancreas allograft rejection and prevents accelerated heart allograft rejection in the rat.
    Chen H; Wu J; Xu D; Luo H; Daloze P
    Transplant Proc; 1993 Feb; 25(1 Pt 1):719-20. PubMed ID: 8438454
    [No Abstract]   [Full Text] [Related]  

  • 25. Synergistic effect of 15-deoxyspergualin and cyclosporine in prolonging survival of rat cardiac allografts.
    Kaji H; Chou DT; Sutherland DE; Stephanian E; Gores PF
    Transplant Proc; 1994 Apr; 26(2):869-70. PubMed ID: 8171689
    [No Abstract]   [Full Text] [Related]  

  • 26. Monoterpene geraniol prevents acute allograft rejection.
    Ji P; Si M; Podnos Y; Imagawa DK
    Transplant Proc; 2002 Aug; 34(5):1418-9. PubMed ID: 12176421
    [No Abstract]   [Full Text] [Related]  

  • 27. Synergistic interactions of cyclosporine, rapamycin, and brequinar on heart allograft survival in mice.
    Stepkowski SM; Tu Y; Chou TC; Kahan BD
    Transplant Proc; 1994 Oct; 26(5):3025-7. PubMed ID: 7940952
    [No Abstract]   [Full Text] [Related]  

  • 28. Reversal of ongoing rejection of allografts by rapamycin.
    Chen HF; Wu JP; Luo HY; Daloze PM
    Transplant Proc; 1991 Aug; 23(4):2241-2. PubMed ID: 1871859
    [No Abstract]   [Full Text] [Related]  

  • 29. Cytokine and alloantibody networks in long-term cardiac allografts in rapamycin-treated sensitized rat recipients.
    Wasowska B; Wieder KJ; Hancock WW; Berse B; Binder J; Strom TB; Kupiec-Weglinski JW
    Transplant Proc; 1995 Feb; 27(1):423-6. PubMed ID: 7879047
    [No Abstract]   [Full Text] [Related]  

  • 30. Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat.
    Stepkowski SM; Chen H; Daloze P; Kahan BD
    Transplantation; 1991 Jan; 51(1):22-6. PubMed ID: 1987691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term in vivo effects of rapamycin on humoral and cellular immune responses in the rat.
    Chen H; Luo H; Daloze P; Xu D; Shan X; St-Louis G; Wu J
    Immunobiology; 1993 Jul; 188(3):303-15. PubMed ID: 8225391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic blood levels of sirolimus (rapamycin) in the allografted rat.
    DiJoseph JF; Fluhler E; Armstrong J; Sharr M; Sehgal SN
    Transplantation; 1996 Oct; 62(8):1109-12. PubMed ID: 8900311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection.
    Schmid C; Heemann U; Azuma H; Tilney NL
    Transplant Proc; 1995 Feb; 27(1):438-9. PubMed ID: 7879053
    [No Abstract]   [Full Text] [Related]  

  • 34. 15AU81, a prostacyclin analog, enhances donor-specific hepatocytes to prolong the survival of rat heart but not small bowel allografts.
    Boyle MJ; Dumble LJ
    Cell Transplant; 1999; 8(5):543-8. PubMed ID: 10580348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression profiles of rat heart allografts with immunosuppression.
    Erickson LM; Yang XF; Pan F; Kobayashi M; Jiang H
    Transplant Proc; 2001; 33(1-2):562-6. PubMed ID: 11266960
    [No Abstract]   [Full Text] [Related]  

  • 36. Synergistic interaction of 15-deoxyspergualin and cyclosporine to prolong the survival of rat islet allografts.
    Gores PF; Field JF; Sutherland DE; Chou TC
    Transplant Proc; 1994 Apr; 26(2):745. PubMed ID: 8171638
    [No Abstract]   [Full Text] [Related]  

  • 37. SDZ RAD, a new rapamycin derivative: synergism with cyclosporine.
    Schuurman HJ; Cottens S; Fuchs S; Joergensen J; Meerloo T; Sedrani R; Tanner M; Zenke G; Schuler W
    Transplantation; 1997 Jul; 64(1):32-5. PubMed ID: 9233697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapamycin prolongs murine islet allograft survival.
    Fabian MC; Lakey JR; Rajotte RV; Kneteman NM
    Transplant Proc; 1992 Dec; 24(6):2842. PubMed ID: 1465966
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of rapamycin on islet xenograft survival.
    Lu X; Schuurman HJ; Borel JF
    Transplant Proc; 1994 Jun; 26(3):1128-9. PubMed ID: 8029857
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment with rapamycin blocks arterial intimal thickening following mechanical and alloimmune injury.
    Gregory CR; Huie P; Shorthouse R; Wang J; Rowan R; Billingham ME; Morris RE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):120-1. PubMed ID: 8438246
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.